UnitedHealth Group Incorporated $UNH Stock: Lockheed Martin Investment Management Co. Reduces Holdings

Lockheed Martin Investment Management Co. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.0% during the 3rd quarter, Holdings Channel reports. The fund owned 9,160 shares of the healthcare conglomerate’s stock after selling 5,610 shares during the period. Lockheed Martin Investment Management Co.’s holdings in UnitedHealth Group were worth $3,362,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of UNH. Wellington Altus USA Inc. raised its holdings in shares of UnitedHealth Group by 97.1% during the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $29,000. Nvwm LLC increased its position in UnitedHealth Group by 89.2% in the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 33 shares in the last quarter. Aberdeen Wealth Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $31,000. Finally, Compass Wealth Management LLC acquired a new position in UnitedHealth Group during the 3rd quarter worth approximately $29,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.19% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a research note on Friday, October 16th. Royal Bank Of Canada increased their target price on UnitedHealth Group from $478.00 to $498.00 and gave the stock an “outperform” rating in a report on Tuesday, October 20th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $529.00 to $531.00 and gave the company an “overweight” rating in a research report on Tuesday, October 27th. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, October 14th. Finally, Weiss Ratings upgraded shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $463.93.

UnitedHealth Group Stock Performance

Shares of UNH opened at $396.97 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The stock has a 50 day moving average price of $390.68 and a two-hundred day moving average price of $364.28. The firm has a market capitalization of $355.70 billion, a P/E ratio of 22.67, a P/E/G ratio of 1.48 and a beta of 0.51. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter last year, the company earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

UnitedHealth Group Company Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.